rhein has been researched along with nsc 23766 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Y; Li, D; Peng, F; Tang, M; Zhong, Y; Zhou, G | 1 |
1 other study(ies) available for rhein and nsc 23766
| Article | Year |
|---|---|
Rhein suppresses matrix metalloproteinase production by regulating the Rac1/ROS/MAPK/AP-1 pathway in human ovarian carcinoma cells.
Topics: Aminoquinolines; Anthraquinones; Cell Line, Tumor; Cell Movement; Female; Humans; JNK Mitogen-Activated Protein Kinases; Matrix Metalloproteinase 2; Matrix Metalloproteinase 3; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Matrix Metalloproteinases; Matrix Metalloproteinases, Secreted; Neoplasm Invasiveness; NM23 Nucleoside Diphosphate Kinases; Ovarian Neoplasms; Phosphorylation; Pyrimidines; rac1 GTP-Binding Protein; Reactive Oxygen Species; Tetradecanoylphorbol Acetate; Tissue Inhibitor of Metalloproteinase-1; Tissue Inhibitor of Metalloproteinase-2; Transcription Factor AP-1 | 2017 |